Universal 'Off-the-Shelf' cell therapy tested for Tough-to-Treat leukemia
Disease control
Not yet recruiting
This early-stage study is testing a new type of cell therapy called 'universal' CLL1 CAR-T for adults with acute myeloid leukemia (AML) that has come back or not responded to standard treatments. The therapy uses genetically modified immune cells designed to find and attack leuke…
Phase: PHASE1 • Sponsor: Mingfeng Zhao • Aim: Disease control
Last updated Mar 30, 2026 14:34 UTC